AHA comments on the 340B section of the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA comments on the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
AHA commends MedPAC and HHS for voicing significant concerns about rising pharmaceutical costs.
AHA provides comments on the consumer-directed health plan legislation being marked up in the Committee on Ways & Means.
The AHA is very pleased that CMS is taking action to improve the operation of the Stark law and counteract its chilling effect on innovation.
The AHA urges the Centers for Medicare & Medicaid Services to expand the data it makes available through standard analytic files and to share currently available data on a timelier basis.
The AHA appreciates the extensive work CMS has done to develop and alternative to the current SNF case-mix system. However, our evaluation of the patient-driven payment model still has several flaws, which must be addressed before the PDPM proposal can be finalized.
The AHA appreciates the extensive work CMS has done to develop and alternative to the current SNF case-mix system. However, our evaluation of the patient-driven payment model still has several flaws, which must be addressed before the PDPM proposal can be finalized.
AHA provides input to CMS on how to better assist patients in accessing pricing information for health care services.
The AHA supports several of the proposed rule’s provisions. In particular, we appreciate and endorse the agency’s proposal to permanently withdraw the 25% Rule; however, we have substantial concerns with the associated budget neutrality adjustment proposed by CMS. We also support the proposed changes related to co-located facilities, and the streamlining of the LTCH quality reporting program. In addition, this letter reiterates our concerns related to underpayment for site-neutral cases.